SENSEX NIFTY
YOU ARE HERE >  MONEYCONTROL MARKETS

Quarterly Growth

Quarterly Growth

Sectoral Screener

Group A| B| S| T| TS| Z|

Pharmaceuticals

View the quarterly growth in the Sales and Net Profits of the various companies as compared to the corresponding quarter last year.

Company name Month Sales (Rs crore) Net Profit (Rs crore)
Latest
Quarter
Quarter
Last Year
% Chg Latest
Quarter
Quarter
Last Year
% Chg
Ajanta Pharma Sep 16 477.74 389.50 22.65 120.95 94.37 28.17
Alembic Pharma Sep 16 829.57 922.54 -10.08 113.83 252.67 -54.95
Aurobindo Pharm Sep 16 2410.16 2175.93 10.76 419.24 340.09 23.27
Biocon Sep 16 617.60 557.30 10.82 70.00 74.10 -5.53
Cadila Health Sep 16 1118.30 1955.20 -42.80 109.00 634.70 -82.83
Cipla Sep 16 2813.99 3070.79 -8.36 329.24 532.09 -38.12
Divis Labs Sep 16 1005.43 964.32 4.26 223.85 295.73 -24.31
Dr Reddys Labs Sep 16 2627.50 2917.30 -9.93 313.20 682.60 -54.12
GlaxoSmithKline Sep 16 799.12 717.53 11.37 98.85 95.55 3.45
Glenmark Sep 16 2171.44 1600.31 35.69 555.83 372.17 49.35
Ipca Labs Sep 16 872.03 749.21 16.39 54.95 11.69 370.06
Jubilant Life Sep 16 575.67 707.40 -18.62 24.12 50.91 -52.62
Lupin Sep 16 2951.28 2540.10 16.19 653.08 486.30 34.30
Marksans Pharma Sep 16 62.21 117.08 -46.87 2.57 28.54 -91.00
Natco Pharma Sep 16 456.25 202.04 125.82 69.55 34.60 101.01
Pfizer Sep 16 557.66 512.11 8.89 126.33 61.64 104.95
Piramal Enter Sep 16 1212.60 784.10 54.65 447.58 290.81 53.91
Sanofi India Sep 16 624.20 585.80 6.56 80.60 72.50 11.17
Strides Shasun Sep 16 516.60 540.49 -4.42 30.72 13.37 129.77
Sun Pharma Sep 16 2029.36 1877.91 8.06 184.54 -600.23 LP*
Sun Pharma Adv Sep 16 94.89 43.12 120.06 14.74 -17.74 LP*
Torrent Pharma Sep 16 1058.00 1566.00 -32.44 169.00 683.00 -75.26
Wockhardt Sep 16 598.28 568.40 5.26 146.16 -39.08 LP*
* PL = Profit to Loss, LP = Loss to Profit.

Note: Increase / Decrease in net profit for the quarter over the corresponding period last year.
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.